Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
BIO 2026: How a gut feeling transformed cancer treatment forever
“Some people thought we were deluded,” Israel Lowy, M.D., Ph.D., said. “But we felt there was something there, and we needed to keep at it."
Will Maddox
Jun 25, 2026 9:23am
Otsuka posts phase 3b ADHD trial win ahead of looming FDA ruling
Jun 25, 2026 9:13am
Redefining PSC success through endpoint research.
Brought to you by
Ipsen
With $15M, BI becomes latest to buy into Immunai’s AI platform
Jun 25, 2026 9:00am
For biopharma manufacturing at speed and scale, the future is flexible
Brought to you by
Resilience
Ionis bags $30M from Recordati for ex-US rare disease rights
Jun 25, 2026 6:59am
More News
Spurned by FDA, Passage Bio finds exit through Remix
Jun 24, 2026 5:20pm
Icon names Microsoft tech partner as Q1 results grow confidence
Jun 24, 2026 3:10pm
Mapp, Gilead antivirals to be deployed in DRC Ebola trial: WHO
Jun 24, 2026 3:03pm
Fierce Pharma
Nature retracts provocative PD-1 time-of-day study
Jun 24, 2026 11:00am
See more stories